{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:49:35Z","timestamp":1789588175878,"version":"build-2803163510"},"reference-count":48,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Allergan, an AbbVie company","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2024,11,30]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To compare the gel stent to trabeculectomy in the Gold-Standard Pathway Study (GPS) patients with primary open-angle glaucoma (POAG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the GPS, patients with elevated intraocular pressure (IOP) poorly controlled with IOP-lowering medication were randomised (2:1, gel stent:trabeculectomy). Aggregate primary endpoint: patients (%) at month 12 achieving \u226520%\u2009IOP reduction from baseline without medication increase, clinical hypotony, vision loss to counting fingers or secondary surgical intervention (SSI). Secondary endpoints included changes in mean IOP and medication count from baseline; postoperative interventions; visual recovery; postoperative complications; and the Symptom and Health Problem Checklist (SHPC-18) questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 130 eyes with POAG treated\/analysed (gel stent, n=88; trabeculectomy, n=42); 61.4% and 69.0% met the primary endpoint, respectively (p=0.394). At month 12, the change from baseline in mean IOP was statistically greater post-trabeculectomy (by 2.8\u2009mm Hg; p=0.028) than post-gel stent. Postoperative intervention and postoperative complication rates were 39.8% and 75.0% (gel stent) versus 76.2% and 92.9% (trabeculectomy), respectively. Hypotony (IOP \u22646\u2009mm Hg at two consecutive visits) rates were 14.8% (gel stent) and 28.6% (trabeculectomy). Visual recovery was faster\/better (per the mean and time to first return to baseline best corrected visual acuity) and SHPC-18-related improvements were greater post-gel stent than post-trabeculectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Similar proportions of eyes with POAG achieved the primary endpoint post-gel stent and post-trabeculectomy. The mean IOP reduction was statistically greater post-trabeculectomy. The gel stent resulted in fewer postoperative interventions, faster\/better visual recovery, favourable patient-reported outcomes and fewer specific adverse events, although more SSIs and IOP elevations were observed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-001696","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T22:35:19Z","timestamp":1738881319000},"page":"e001696","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness and safety of the XEN45 gel stent compared to trabeculectomy in primary open-angle glaucoma: the Gold-Standard Pathway Study"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct03654885","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Iqbal Ike K","family":"Ahmed","sequence":"first","affiliation":[{"name":"John Moran Eye Center, University of Utah, Salt Lake City, Utah, USA"},{"name":"Prism Eye Institute, Oakville, Ontario, Canada"},{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2294-0055","authenticated-orcid":false,"given":"Vanessa","family":"Vera","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie company, Irvine, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Stalmans","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Hospitals UZ Leuven, Leuven, Belgium"},{"name":"Group of Ophthalmology, Department of Neurosciences, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-6054","authenticated-orcid":false,"given":"Antonio Maria","family":"Fea","sequence":"additional","affiliation":[{"name":"Struttura Complessa Oculistica, Citt\u00e0 Della Salute e Della Scienza di Torino, Dipartimento di Scienze Chirurgiche, Universit\u00e0 Degli Studi di Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3068-3737","authenticated-orcid":false,"given":"Kaweh","family":"Mansouri","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Denver, Denver, CO, USA"},{"name":"Glaucoma Research Center, Montchoisi Clinic, Swiss Visio, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Gu","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie company, Irvine, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2077-659X","authenticated-orcid":false,"given":"Earl Randy","family":"Craven","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie company, Irvine, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert A","family":"Reitsamer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, University Clinic Salzburg, SALK\/Paracelsus Medical University, Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"2026010721201638000_10.1.e001696.1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317112"},{"key":"2026010721201638000_10.1.e001696.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.10.022"},{"key":"2026010721201638000_10.1.e001696.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.02.003"},{"key":"2026010721201638000_10.1.e001696.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.07.020"},{"key":"2026010721201638000_10.1.e001696.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100578","article-title":"Meta-analysis of randomized controlled trials comparing EX-PRESS implantation with trabeculectomy for open-angle glaucoma","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"2026010721201638000_10.1.e001696.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086045","article-title":"EX-PRESS implantation versus trabeculectomy in open-angle glaucoma: a meta-analysis of randomized controlled clinical trials","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS ONE"},{"key":"2026010721201638000_10.1.e001696.7","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32834ff2d1"},{"key":"2026010721201638000_10.1.e001696.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.10.024"},{"key":"2026010721201638000_10.1.e001696.9","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3283360b68"},{"key":"2026010721201638000_10.1.e001696.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.06.018"},{"key":"2026010721201638000_10.1.e001696.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.07.022"},{"key":"2026010721201638000_10.1.e001696.12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11226833","article-title":"Minimally invasive glaucoma surgery: safety of individual devices","volume":"11","author":"Rowson","year":"2022","journal-title":"J Clin Med"},{"key":"2026010721201638000_10.1.e001696.13","first-page":"251584142211256967","article-title":"A comparison of iStent combined with phacoemulsification and endocyclophotocoagulation (ICE2) with the PreserFlo MicroShunt and XEN-45 implants","volume":"14","author":"Qidwai","year":"2022","journal-title":"Ther Adv Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajo.2023.03.026","article-title":"Gel stent versus trabeculectomy: the randomized, multicenter, Gold-Standard Pathway Study (GPS) of effectiveness and safety at 12 months","volume":"252","author":"Sheybani","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.15","unstructured":"Glaukos Corporation . Patient information brochure: name of medical device: PreserFlo MicroShunt & 3mm scleral marker. 2021. Available: https:\/\/www.glaukos.com\/wp-content\/uploads\/2021\/11\/GLT-001-PRESERFLO-MicroShunt.pdf"},{"key":"2026010721201638000_10.1.e001696.16","unstructured":"AqueSys Inc . Directions for use for the xen\u00b745 glaucoma treatment system. 2020. Available: https:\/\/allergan-web-cdn-prod.azureedge.net\/allergancanadaspecialty\/allergancanadaspecialty\/media\/actavis-canada-specialty\/en\/products\/pms\/xen-45-dfu-english-3037-004-rev-a.pdf"},{"key":"2026010721201638000_10.1.e001696.17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaophthalmol.2017.4574","article-title":"Development of an 18-Item measure of symptom burden in patients with glaucoma from the Collaborative Initial Glaucoma Treatment Study\u2019s Symptom and Health Problem Checklist","volume":"135","author":"Musch","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.18","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.ophtha.2017.05.004","article-title":"Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy","volume":"124","author":"Schlenker","year":"2017","journal-title":"Ophthalmology"},{"key":"2026010721201638000_10.1.e001696.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76551-y","article-title":"Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study","volume":"10","author":"Theilig","year":"2020","journal-title":"Sci Rep"},{"key":"2026010721201638000_10.1.e001696.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231614","article-title":"Efficacy and safety of XEN-implantation vs. trabeculectomy: data of a \u201creal-world\u201d setting","volume":"15","author":"Wagner","year":"2020","journal-title":"PLoS One"},{"key":"2026010721201638000_10.1.e001696.21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/08820538.2021.1931356","article-title":"A retrospective comparison of trabeculectomy, Baerveldt glaucoma implant, and microinvasive glaucoma surgeries in a three-year follow-up","volume":"36","author":"Nuzzi","year":"2021","journal-title":"Semin Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.22","article-title":"Functional monitoring after trabeculectomy or XEN microstent implantation using spectral domain optical coherence tomography and visual field indices-a retrospective comparative cohort study","volume":"10","author":"Schargus","year":"2021","journal-title":"Biology (Basel)"},{"key":"2026010721201638000_10.1.e001696.23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00417-019-04341-y","article-title":"XEN implant device versus trabeculectomy, either alone or in combination with phacoemulsification, in open-angle glaucoma patients","volume":"257","author":"Marcos Parra","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/IJG.0000000000000858","article-title":"Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results","volume":"27","author":"Mansouri","year":"2018","journal-title":"J Glaucoma"},{"key":"2026010721201638000_10.1.e001696.25","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1111\/aos.14886","article-title":"Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study","volume":"100","author":"Reitsamer","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00417-019-04251-z","article-title":"Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma","volume":"257","author":"Reitsamer","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.27","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.804847","article-title":"The outcomes of XEN gel stent implantation: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2026010721201638000_10.1.e001696.28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2017.07.023","article-title":"Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months","volume":"183","author":"Grover","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ogla.2018.10.003","article-title":"Standalone ab interno gelatin stent versus trabeculectomy: postoperative interventions, visual outcomes, and visits","volume":"1","author":"Schlenker","year":"2018","journal-title":"Ophthalmol Glaucoma"},{"key":"2026010721201638000_10.1.e001696.30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5005\/jp-journals-10078-1287","article-title":"Comparison of ab interno XEN gelatin stent vs trabeculectomy with mitomycin C: a retrospective study","volume":"14","author":"Sharpe","year":"2020","journal-title":"J Curr Glaucoma Pract"},{"key":"2026010721201638000_10.1.e001696.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256362","article-title":"24-month outcomes of XEN45 gel implant versus trabeculectomy in primary glaucoma","volume":"16","author":"Wanichwecharungruang","year":"2021","journal-title":"PLoS One"},{"key":"2026010721201638000_10.1.e001696.32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2017.01.019","article-title":"Quality of life in the Tube Versus Trabeculectomy Study","volume":"176","author":"Kotecha","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000830","article-title":"Trabeculectomy versus Xen gel implant for the treatment of open-angle glaucoma: a 3-year retrospective analysis","volume":"7","author":"Cappelli","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/IJG.0000000000001734","article-title":"Long-term results of the PreserFlo microshunt in patients with primary open-angle glaucoma from a single-center nonrandomized study","volume":"30","author":"Batlle","year":"2021","journal-title":"J Glaucoma"},{"key":"2026010721201638000_10.1.e001696.35","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s12325-021-01811-w","article-title":"Efficacy and safety of PreserFlo MicroShunt after a failed trabeculectomy in eyes with primary open-angle glaucoma: a retrospective study","volume":"38","author":"Quaranta","year":"2021","journal-title":"Adv Ther"},{"key":"2026010721201638000_10.1.e001696.36","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041677","article-title":"Systematic PreserFlo MicroShunt intraluminal stenting for hypotony prevention in highly myopic patients: a comparative study","volume":"12","author":"Lupardi","year":"2023","journal-title":"J Clin Med"},{"key":"2026010721201638000_10.1.e001696.37","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134474","article-title":"Long-term outcomes of the PreserFlo MicroShunt implant in a heterogeneous glaucoma cohort","volume":"12","author":"Storp","year":"2023","journal-title":"J Clin Med"},{"key":"2026010721201638000_10.1.e001696.38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/aos.15727","article-title":"Hypotony in the early postoperative period after MicroShunt implantation versus trabeculectomy: a registry study","volume":"102","author":"B\u00f8hler","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"2026010721201638000_10.1.e001696.39","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13071979","article-title":"PreserFlo MicroShunt: 1-year results of a 25-gauge vs. 27-gauge needle tract","volume":"13","author":"Steiner","year":"2024","journal-title":"J Clin Med"},{"key":"2026010721201638000_10.1.e001696.40","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-320631"},{"key":"2026010721201638000_10.1.e001696.41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.18502\/jovr.v19i1.15443","article-title":"Contemporary approach to narrow angles","volume":"19","author":"Shamseldin Shalaby","year":"2024","journal-title":"J Ophthalmic Vis Res"},{"key":"2026010721201638000_10.1.e001696.42","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.1231"},{"key":"2026010721201638000_10.1.e001696.43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ogla.2018.08.002","article-title":"Risk factors associated with missed diagnoses of narrow angles by the Van Herick technique","volume":"1","author":"Thompson","year":"2018","journal-title":"Ophthalmol Glaucoma"},{"key":"2026010721201638000_10.1.e001696.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.11.016"},{"key":"2026010721201638000_10.1.e001696.45","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e318264ba68"},{"key":"2026010721201638000_10.1.e001696.46","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.167296"},{"key":"2026010721201638000_10.1.e001696.47","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.624179","article-title":"Prevalence of primary angle closure glaucoma in the last 20 years: a meta-analysis and systematic review","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2026010721201638000_10.1.e001696.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-001696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:20:35Z","timestamp":1767849635000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,6]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjophth-2024-001696"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-001696","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}